10.17
price down icon0.88%   -0.09
after-market After Hours: 10.17
loading
Tyra Biosciences Inc stock is traded at $10.17, with a volume of 626.22K. It is down -0.88% in the last 24 hours and down -3.14% over the past month. Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
See More
Previous Close:
$10.26
Open:
$10.24
24h Volume:
626.22K
Relative Volume:
1.86
Market Cap:
$540.84M
Revenue:
-
Net Income/Loss:
$-83.74M
P/E Ratio:
-6.3168
EPS:
-1.61
Net Cash Flow:
$-64.98M
1W Performance:
+9.95%
1M Performance:
-3.14%
6M Performance:
-32.96%
1Y Performance:
-46.56%
1-Day Range:
Value
$9.37
$10.39
1-Week Range:
Value
$8.88
$10.39
52-Week Range:
Value
$6.42
$29.60

Tyra Biosciences Inc Stock (TYRA) Company Profile

Name
Name
Tyra Biosciences Inc
Name
Phone
(619) 728-4760
Name
Address
2656 STATE STREET, CARLSBAD
Name
Employee
60
Name
Twitter
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
TYRA's Discussions on Twitter

Compare TYRA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TYRA
Tyra Biosciences Inc
10.17 491.90M 0 -83.74M -64.98M -1.61
Biotechnology icon
ONC
Beone Medicines Ltd Adr
257.00 26.69B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
443.82 114.81B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.282 41.83M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
85.54 6.60B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
483.07 65.36B 14.09B 4.50B 2.96B 39.28

Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades

Date Action Analyst Rating Change
May-21-25 Resumed Piper Sandler Overweight
Jan-07-25 Initiated UBS Buy
Oct-18-24 Upgrade BofA Securities Neutral → Buy
Aug-15-24 Initiated Piper Sandler Overweight
Dec-15-23 Downgrade BofA Securities Buy → Neutral
Jun-30-23 Initiated Wedbush Outperform
Feb-03-23 Initiated Oppenheimer Outperform
Jun-23-22 Initiated H.C. Wainwright Buy
Mar-08-22 Upgrade Jefferies Hold → Buy
Nov-08-21 Downgrade Jefferies Buy → Hold
Oct-11-21 Initiated BofA Securities Buy
Oct-11-21 Initiated Cowen Outperform
Oct-11-21 Initiated Jefferies Buy
View All

Tyra Biosciences Inc Stock (TYRA) Latest News

pulisher
Jun 05, 2025

Trend Tracker for (TYRA) - news.stocktradersdaily.com

Jun 05, 2025
pulisher
Jun 03, 2025

BNP Paribas Financial Markets Purchases New Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Deutsche Bank AG Acquires 6,466 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Jun 02, 2025
pulisher
May 30, 2025

Millennium Management LLC Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 30, 2025
pulisher
May 29, 2025

Tyra Bioscience Holds 2025 Annual Stockholders Meeting - TipRanks

May 29, 2025
pulisher
May 28, 2025

TYRA Stock: Upcoming Oppenheimer Meeting Announcement | TYRA Sto - GuruFocus

May 28, 2025
pulisher
May 25, 2025

Trading (TYRA) With Integrated Risk Controls - news.stocktradersdaily.com

May 25, 2025
pulisher
May 24, 2025

Northern Trust Corp Grows Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 24, 2025
pulisher
May 23, 2025

Piper Sandler Begins Coverage on Tyra Biosciences (NASDAQ:TYRA) - Defense World

May 23, 2025
pulisher
May 22, 2025

HC Wainwright Forecasts Higher Earnings for Tyra Biosciences - Defense World

May 22, 2025
pulisher
May 22, 2025

What is HC Wainwright’s Forecast for TYRA FY2026 Earnings? - Defense World

May 22, 2025
pulisher
May 21, 2025

Tyra Biosciences (TYRA) Receives Overweight Rating from Piper Sandler | TYRA Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Tyra Biosciences (TYRA): Analyst Bullish with Overweight Rating and $33 Target | TYRA Stock News - GuruFocus

May 21, 2025
pulisher
May 17, 2025

Dimensional Fund Advisors LP Increases Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 17, 2025
pulisher
May 15, 2025

(TYRA) Trading Report - news.stocktradersdaily.com

May 15, 2025
pulisher
May 14, 2025

Transcript : Tyra Biosciences, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 05 - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Tyra Biosciences Reports Increased R&D Investment in Q1 2025 - TipRanks

May 13, 2025
pulisher
May 12, 2025

Tyra Biosciences to Participate at Upcoming Investor Conferences - Citizen Tribune

May 12, 2025
pulisher
May 12, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of “Buy” by Brokerages - Defense World

May 12, 2025
pulisher
May 11, 2025

Wells Fargo & Company MN Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 11, 2025
pulisher
May 10, 2025

What Will Tyra Biosciences Inc (NASDAQ: TYRA) Be Like In 2025 - Stocksregister

May 10, 2025
pulisher
May 09, 2025

Tyra Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 09, 2025
pulisher
May 09, 2025

One Tyra Biosciences Insider Raised Stake By 284% In Previous Year - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Barclays PLC Grows Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

May 09, 2025
pulisher
May 08, 2025

Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (NASDAQ:TYRA) and Encourages Investors to Contact the Firm for Additional Information - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Tyra Biosciences (TYRA) Secures Financial Stability for Oncology Advancements | TYRA Stock News - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Tyra Biosciences Reports First Quarter 2025 Financial Results and Highlights - Kilgore News Herald

May 08, 2025
pulisher
May 07, 2025

Analytical Lens: Exploring Tyra Biosciences Inc (TYRA)’s Financial Story Through Ratios - DWinneX

May 07, 2025
pulisher
May 07, 2025

54,783 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Acquired by Raymond James Financial Inc. - Defense World

May 07, 2025
pulisher
May 05, 2025

29,100 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Renaissance Technologies LLC - Defense World

May 05, 2025
pulisher
May 05, 2025

Tyra Biosciences Inc expected to post a loss of 49 cents a shareEarnings Preview - TradingView

May 05, 2025
pulisher
May 01, 2025

Tyra Biosciences (TYRA) to Release Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 27, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Shares Sold by JPMorgan Chase & Co. - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Russell Investments Group Ltd. Acquires 10,447 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 25, 2025

Geode Capital Management LLC Has $7.20 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 25, 2025
pulisher
Apr 24, 2025

Tyra Biosciences Inc [TYRA] Records 50-Day SMA of $10.39 - knoxdaily.com

Apr 24, 2025
pulisher
Apr 24, 2025

Should investors be concerned about Tyra Biosciences Inc (TYRA)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 22, 2025

Northrop Grumman Posts Downbeat Results, Joins Halliburton And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga

Apr 22, 2025
pulisher
Apr 20, 2025

Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.83 Average PT from Brokerages - Defense World

Apr 20, 2025
pulisher
Apr 19, 2025

(TYRA) Investment Analysis and Advice - news.stocktradersdaily.com

Apr 19, 2025
pulisher
Apr 17, 2025

Vanguard Group Inc. Sells 37,643 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 17, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Has $1.32 Million Stock Position in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

American Century Companies Inc. Sells 20,857 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

Why WaFd Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 14, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Buys New Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 13, 2025
pulisher
Apr 08, 2025

TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm! - ACCESS Newswire

Apr 08, 2025
pulisher
Apr 07, 2025

Advanced Urothelial Carcinoma Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - Barchart.com

Apr 07, 2025
pulisher
Apr 06, 2025

Raymond James Financial Inc. Invests $761,000 in Tyra Biosciences, Inc. (NASDAQ:TYRA) - Defense World

Apr 06, 2025
pulisher
Apr 04, 2025

HC Wainwright Predicts Reduced Earnings for Tyra Biosciences - Defense World

Apr 04, 2025
pulisher
Apr 03, 2025

Tyra Biosciences stock hits 52-week low at $8.14 - Investing.com Australia

Apr 03, 2025

Tyra Biosciences Inc Stock (TYRA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.15
price down icon 0.86%
$580.59
price up icon 1.24%
$308.00
price up icon 0.88%
$36.54
price up icon 1.27%
$4.8111
price up icon 1.29%
$483.07
price down icon 0.38%
Cap:     |  Volume (24h):